Skip to content

The Effect of Cinnamon Extract on Reducing Perineal Pain Following Episiotomy in Primiparous Women in Khorramabad Asali Hospital in 2014

Effect of Cinnamon Extract on Reducing Perineal Pain Following Episiotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015012420734N2
Enrollment
68
Registered
2015-06-03
Start date
2014-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perineal laceration during delivery. Perineal laceration during delivery Incl.: episiotomy extended by laceration

Interventions

Intervention 1: Intervention group will receive a specific dosage of cinnamon extract (3.5%) And will be applied at the site of episiotomy then, in 1 and 4 hours after use also will be used. Residual
Treatment - Drugs
Placebo
Intervention group will receive a specific dosage of cinnamon extract (3.5%) And will be applied at the site of episiotomy then, in 1 and 4 hours after use also will be used. Residual extract will be
Control group will receive a specific dosage of placebo and will be applied at the site of episiotomy then, in 1 and 4 hours after use also will be used. Residual placebo will be given to them to use

Sponsors

Lorestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Primiparous woman; Educated; Iranian; body mass index between 19/8-25 kg/m2 ;first degree episiotomy wound with a length of 3-4 cm and a depth of up to 3 mm; singleton term(37-42 weeks) pregnancy; 18 to 35 years old; No underlying medical condition(Cardiovascular, hepatic, renal, diabetes, coagulation disorders, anemia, constant constipation and hemorrhoids) ; absence of chemotherapy and allergy to Herbal Medicines; Not taking anticoagulant drugs; antidepressants; anticonvulsants; antibiotics; immunosuppressive drugs; alcohol; smoking and opiate materials; No history of active skin disease (allergic disorder, symptomatic vaginitis, Skin ulcer or sensitivity at the site) ; anterior position view of the fetal head for episiotomy on the gynecologic bed. Exclusion criteria: Occurring Hematomas; Infection; need for neonatal resuscitation; development of episiotomy; abnormal bleeding after childbirth; perineal re-manipulation; Prolonged rupture of membranes (more than 18 hours) ; the first stage of labor (over 14 hours) ; second phase of pregnancy (more than 2 hours); the third stage of labor (more than 1 hour); The need to use instrument for delivery; grade 3 or 4 Perineal laceration.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of episiotomy site pain. Timepoint: Immediately after surgery, 0 and 1 and 4 hours after episiotomy. Method of measurement: Visual graded scale.

Secondary

MeasureTime frame
Adverse reactions (allergy). Timepoint: At one and four ?hours after the surgery, the tenth visit day, any unpredictable time. Method of measurement: By examination and regular visits and record patient pain complaint.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoume Ghafarzadeh

lorestan university of Medical science

dr.ghafarzade@gmail.com+98 66 3343 0637

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026